Drug
S64315 Once A Week
S64315 Once A Week: highest development phase Phase 1, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| S64315 once a week NCT02979366 | Phase 1 | Acute Myeloid Leukaemia (AML) |
Latest
No recent events.
Follow S64315 Once A Week on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.